These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9922075)

  • 1. Molecular abnormalities in myeloid leukemias and myelodysplastic syndromes.
    Sawyers CL
    Leuk Res; 1998 Dec; 22(12):1113-22. PubMed ID: 9922075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cancer and fusion gene].
    Nakata M; Ohki M
    Tanpakushitsu Kakusan Koso; 1997 Sep; 42(12):1978-90. PubMed ID: 9301327
    [No Abstract]   [Full Text] [Related]  

  • 3. New mechanisms of AML1 gene alteration in hematological malignancies.
    Roumier C; Fenaux P; Lafage M; Imbert M; Eclache V; Preudhomme C
    Leukemia; 2003 Jan; 17(1):9-16. PubMed ID: 12529654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
    Lo Coco F; Pisegna S; Diverio D
    Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AML-1 mutations outside the RUNT domain: description of two cases in myeloid malignancies.
    Carnicer MJ; Nomdedéu JF; Lasa A; Bellido M; Aventín A; Baiget M; Sierra J
    Leukemia; 2002 Nov; 16(11):2329-32. PubMed ID: 12399980
    [No Abstract]   [Full Text] [Related]  

  • 6. The chimeric genes AML1/MDS1 and AML1/EAP inhibit AML1B activation at the CSF1R promoter, but only AML1/MDS1 has tumor-promoter properties.
    Zent CS; Mathieu C; Claxton DF; Zhang DE; Tenen DG; Rowley JD; Nucifora G
    Proc Natl Acad Sci U S A; 1996 Feb; 93(3):1044-8. PubMed ID: 8577711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations of the AML1 transcription factor in human leukemia.
    Downing JR; Higuchi M; Lenny N; Yeoh AE
    Semin Cell Dev Biol; 2000 Oct; 11(5):347-60. PubMed ID: 11105899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analyses of the mutations of AML 1 gene in myelodysplastic syndromes].
    Yoichi I
    Rinsho Ketsueki; 2002 Mar; 43(3):139-45. PubMed ID: 11979742
    [No Abstract]   [Full Text] [Related]  

  • 9. Consistent intergenic splicing and production of multiple transcripts between AML1 at 21q22 and unrelated genes at 3q26 in (3;21)(q26;q22) translocations.
    Nucifora G; Begy CR; Kobayashi H; Roulston D; Claxton D; Pedersen-Bjergaard J; Parganas E; Ihle JN; Rowley JD
    Proc Natl Acad Sci U S A; 1994 Apr; 91(9):4004-8. PubMed ID: 8171026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lineage specificity of CBFA2 fusion transcripts.
    Dann EJ; Fears S; Arád-Dann H; Nucifora G; Rowley JD
    Leuk Res; 2000 Jan; 24(1):11-7. PubMed ID: 10634640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rearrangements of the AML1/CBFA2 gene in myeloid leukemia with the 3;21 translocation: in vitro and in vivo studies.
    Zent C; Rowley JD; Nucifora G
    Leukemia; 1997 Apr; 11 Suppl 3():273-8. PubMed ID: 9209363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unlike AML1, CBFbeta gene is not deregulated by point mutations in acute myeloid leukemia and in myelodysplastic syndromes.
    Leroy H; Roumier C; Grardel-Duflos N; Macintyre E; Lepelley P; Fenaux P; Preudhomme C
    Blood; 2002 May; 99(10):3848-50. PubMed ID: 11986246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. t(3;21)(q26;q22) in myeloid leukemia: an aggressive syndrome of blast transformation associated with hydroxyurea or antimetabolite therapy.
    Yin CC; Cortes J; Barkoh B; Hayes K; Kantarjian H; Jones D
    Cancer; 2006 Apr; 106(8):1730-8. PubMed ID: 16532439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 3;21 translocation in myelodysplasia results in a fusion transcript between the AML1 gene and the gene for EAP, a highly conserved protein associated with the Epstein-Barr virus small RNA EBER 1.
    Nucifora G; Begy CR; Erickson P; Drabkin HA; Rowley JD
    Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7784-8. PubMed ID: 8395054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of the polymerase chain reaction in the detection of AML1/ETO fusion transcript in t(8;21).
    Kwong YL; Chan V; Wong KF; Chan TK
    Cancer; 1995 Feb; 75(3):821-5. PubMed ID: 7828132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intergenic splicing of MDS1 and EVI1 occurs in normal tissues as well as in myeloid leukemia and produces a new member of the PR domain family.
    Fears S; Mathieu C; Zeleznik-Le N; Huang S; Rowley JD; Nucifora G
    Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1642-7. PubMed ID: 8643684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of CBFB/MYH11 transcripts in patients with inversion and other abnormalities of chromosome 16 at presentation and remission.
    Tobal K; Johnson PR; Saunders MJ; Harrison CJ; Liu Yin JA
    Br J Haematol; 1995 Sep; 91(1):104-8. PubMed ID: 7577615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection of t(3 ; 21) (q26 ; q22) with AML1/EVI1 mRNA during progression of myelodysplastic syndrome to acute myeloid leukemia].
    Choi I; Goto T; Nagano M; Muta K; Yufu Y; Uike N; Kozuru M; Abe Y; Nisimura J
    Rinsho Ketsueki; 1999 Jun; 40(6):518-20. PubMed ID: 10422292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pericentric chromosome 8 inversion associated with the 5'RUNX1/3'CBFA2T1 gene in acute myeloid leukemia cases.
    Anelli L; Albano F; Zagaria A; Liso A; Cuneo A; Mancini M; Liso V; Rocchi M; Specchia G
    Ann Hematol; 2005 Apr; 84(4):245-9. PubMed ID: 15551097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [EVI1 and its role in myelodysplastic syndrome, myeloid leukemia and other malignant diseases].
    Fuchs O
    Cas Lek Cesk; 2006; 145(8):619-24. PubMed ID: 16995417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.